Lambda Biologics provides state-of-the-art organoid-based disease modeling and drug evaluation services. Utilizing human induced pluripotent stem cells (iPSCs), our platform generates three-dimensional organoids that accurately recapitulate organ structure and function. This enables precise modeling of disease mechanisms and predictive assessment of therapeutic compounds.
Organoids mimic human tissue architecture and cellular heterogeneity, providing more translationally relevant data than traditional 2D cultures or animal models.
